Preventive effects of 23-valent pneumococcal polysaccharide vaccine on community-acquired pneumonia hospitalization in older individuals in China: A case-control study

The effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPSV23) against hospitalization risk due to all-cause community-acquired pneumonia (CAP) in older individuals in China is limited. A hospital-based case-control study was conducted on this issue in Suzhou City, Jiangsu Province, Chi...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Na Liu, Lei Wang, Lin Luan, Huaqing Wang
Format:	Artigo
Język:	Inglês
Wydane:	Taylor & Francis Group 2024-12-01
Seria:	Human Vaccines & Immunotherapeutics
Hasła przedmiotowe:	23-valent pneumococcal polysaccharide vaccine vaccine effectiveness community-acquired pneumonia hospitalization risk older individuals
Dostęp online:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2420450
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!